Human Reproduction, Vol 12, 387-389, Copyright © 1997 by Oxford University Press
K Clifford, R Rai and L Regan
The future pregnancy outcome of 201 consecutive women, median age 34 years
(range 22-43), with a history of unexplained recurrent first trimester
miscarriage (median 3; range 3-13), was studied. All women and their
partners had normal peripheral blood karyotypes; none had antiphospholipid
antibodies and none hypersecreted luteinizing hormone (LH). No
pharmacological treatment was prescribed and early pregnancy supportive
care was encouraged. Women aged < or = 30 years had a subsequent
miscarriage rate of 25% (14/57) which rose to 52% (13/25) in women aged
> or = 40 years (P = 0.02). After three consecutive miscarriages, the
risk of miscarriage of the next pregnancy was 29% (34/119) but increased to
53% (9/17) after six or more previous losses (P = 0.04). A past history of
a livebirth did not influence the outcome of the next pregnancy. Supportive
care in early pregnancy conferred a significant beneficial effect on
pregnancy outcome. Of 160 women who attended the early pregnancy clinic, 42
(26%) miscarried in the next pregnancy compared with 21 out of 41 (51%) who
did not attend the clinic (P = 0.002). After thorough investigation, women
with unexplained recurrent first trimester miscarriage have an excellent
pregnancy outcome without pharmacological intervention if offered
supportive care alone in the setting of a dedicated miscarriage clinic.
ARTICLES
Future pregnancy outcome in unexplained recurrent first trimester miscarriage
Department of Obstetrics and Gynaecology, Imperial College School of Medicine at St. Mary's, London, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
The ESHRE Capri Workshop Group Genetic aspects of female reproduction Hum. Reprod. Update, April 2, 2008; (2008) dmn009v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.E. Hiby, L. Regan, W. Lo, L. Farrell, M. Carrington, and A. Moffett Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage Hum. Reprod., April 1, 2008; 23(4): 972 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.A. Cocksedge, S.H. Saravelos, Q. Wang, E. Tuckerman, S.M. Laird, and T.C. Li Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Hum. Reprod., April 1, 2008; 23(4): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tuckerman, S.M. Laird, A. Prakash, and T.C. Li Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage Hum. Reprod., August 1, 2007; 22(8): 2208 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, W. S. B. Yeung, and P. C. Ho Endometrial and subendometrial vascularity is higher in pregnant patients with livebirth following ART than in those who suffer a miscarriage Hum. Reprod., April 1, 2007; 22(4): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Donoso, C. Staessen, B.C.J.M. Fauser, and P. Devroey Current value of preimplantation genetic aneuploidy screening in IVF Hum. Reprod. Update, January 1, 2007; 13(1): 15 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shakhar, E. Rosenne, R. Loewenthal, G. Shakhar, H. Carp, and B.-E. Shamgar High NK cell activity in recurrent miscarriage: what are we really measuring? Hum. Reprod., September 1, 2006; 21(9): 2421 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jauniaux, R. G. Farquharson, O. B. Christiansen, N. Exalto, and On behalf of ESHRE Special Interest Group for Earl Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage Hum. Reprod., September 1, 2006; 21(9): 2216 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weiss, E. Shalev, and S. Romano Hysteroscopy may be justified after two miscarriages Hum. Reprod., September 1, 2005; 20(9): 2628 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kavalier Investigation of recurrent miscarriages BMJ, July 16, 2005; 331(7509): 121 - 122. [Full Text] [PDF] |
||||
![]() |
O. M.H. Habayeb and J. C. Konje The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome Hum. Reprod., December 1, 2004; 19(12): 2952 - 2958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moffett, L. Regan, and P. Braude Natural killer cells, miscarriage, and infertility BMJ, November 27, 2004; 329(7477): 1283 - 1285. [Full Text] [PDF] |
||||
![]() |
H.J.A. Carp, M. Dirnfeld, J. Dor, and J.G. Grudzinskas ART in recurrent miscarriage: preimplantation genetic diagnosis/screening or surrogacy? Hum. Reprod., July 1, 2004; 19(7): 1502 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.L. Tower and L. Regan Intrauterine haematomas in a recurrent miscarriage population Hum. Reprod., September 1, 2001; 16(9): 2005 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jivraj, B. Anstie, Y-C. Cheong, F.M. Fairlie, S.M. Laird, and T.C. Li Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study Hum. Reprod., January 1, 2001; 16(1): 102 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.H. Rushworth, M. Backos, R. Rai, I.T. Chilcott, N. Baxter, and L. Regan Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies Hum. Reprod., July 1, 2000; 15(7): 1637 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.A. Brigham, C. Conlon, and R.G. Farquharson A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage Hum. Reprod., November 1, 1999; 14(11): 2868 - 2871. [Abstract] [Full Text] [PDF] |
||||


